Artiva Biotherapeutics earnings were -$75.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest ARTV earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$21.3M, up 4.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ARTV reported annual earnings of -$65.4M, with 127.6% growth. The next ARTV earnings date is Aug 28, 2025.
Artiva Biotherapeutics Earnings Reports & History FAQ
What were Artiva Biotherapeutics's earnings last quarter?
On ARTV's earnings call on Invalid Date, Artiva Biotherapeutics (NASDAQ: ARTV) reported Q2 2025 earnings per share (EPS) of -$0.87, up 96.05% year over year. Total ARTV earnings for the quarter were -$21.25 million. In the same quarter last year, Artiva Biotherapeutics's earnings per share (EPS) was -$22.00.
The next ARTV earnings call is Invalid Date. Add ARTV to your watchlist to be reminded of Artiva Biotherapeutics's next earnings date.
Is Artiva Biotherapeutics profitable or losing money?
As of the last Artiva Biotherapeutics earnings report, Artiva Biotherapeutics is currently losing money. Artiva Biotherapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$75.13 million, a 131% increase year over year.
What was ARTV's earnings growth in the past year?
As of Artiva Biotherapeutics's earnings date in Invalid Date, Artiva Biotherapeutics's earnings has grown year over year. ARTV earnings in the past year totalled -$75.13 million.
What are Artiva Biotherapeutics's earnings expectations?
The current EPS estimate for Artiva Biotherapeutics's earnings report in Invalid Date is -$0.77.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.